Cargando…

Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma

Cholangiocarcinoma (CCA) is characterized by a uniquely aggressive behavior and lack of effective targeted therapies. After analyzing the gene expression profiles of seven paired intrahepatic CCA microarrays, a novel sphingosine kinase 1 (SPHK1)/sphingosine-1-phosphate (S1P) pathway and a novel targ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ming-Huang, Yen, Chueh-Chuan, Cheng, Chi-Tung, Wu, Ren-Chin, Huang, Shih-Chiang, Yu, Chung-Shan, Chung, Yi-Hsiu, Liu, Chun-Yu, Chang, Peter Mu-Hsin, Chao, Yee, Chen, Ming-Han, Chen, Yu-Fen, Chiang, Kun-Chun, Yeh, Ta-Sen, Chen, Tzu Chi, Huang, Chi-Ying F., Yeh, Chun-Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695139/ https://www.ncbi.nlm.nih.gov/pubmed/26090720

Ejemplares similares

Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma
por: Chen, Ming-Huang, et al.
Publicado: (2014)

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
por: Cheng, Chi-Tung, et al.
Publicado: (2015)

Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients
por: Yeh, Chun-Nan, et al.
Publicado: (2017)

Role of PLK1 signaling pathway genes in gastrointestinal stromal tumors
por: Chen, Jen-Shi, et al.
Publicado: (2018)

Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival
por: Chiang, Kun-Chun, et al.
Publicado: (2019)

Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma
por: Chiang, Kun-Chun, et al.
Publicado: (2017)

Reappraisal of the Therapeutic Role of Celecoxib in Cholangiocarcinoma
por: Yeh, Chun-Nan, et al.
Publicado: (2013)

Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation
por: Pan, Yi-Ru, et al.
Publicado: (2023)

Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors
por: Yeh, Chun-Nan, et al.
Publicado: (2014)

Synthesis and evaluation of ortho-[(18)F] fluorocelecoxib for COX-2 cholangiocarcinoma imaging
por: Chang, Chi-Wei, et al.
Publicado: (2018)

Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib
por: Chang, Shih-Chun, et al.
Publicado: (2016)

Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma
por: Yeh, Chun-Nan, et al.
Publicado: (2014)

Chemopreventive and chemotherapeutic effects of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model
por: Chiang, Kun-Chun, et al.
Publicado: (2014)

Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients
por: Tsai, Chun-Yi, et al.
Publicado: (2022)

Fractioned Dose Regimen of Sunitinib for Patients with Gastrointestinal Stromal Tumor: A Pharmacokinetic and Treatment Efficacy Study()
por: Chen, Yen-Yang, et al.
Publicado: (2014)

Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma
por: Chang, Yu-Chan, et al.
Publicado: (2020)

Dataset on the synthesis and characterization of boron fenbufen and its F-18 labeled homolog
por: Yeh, Chun-Nan, et al.
Publicado: (2017)

Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022)

Sliding and pressure evaluation on conventional and V-shaped seats of reclining wheelchairs for stroke patients with flaccid hemiplegia: a crossover trial
por: Huang, Hsiu-Chen, et al.
Publicado: (2011)

Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
por: Chan, Kun-Ming, et al.
Publicado: (2018)

484. A Severity Score for Predicting In-Hospital Death in Patients With Clostridium difficile Infection: A Hospital-Based Cohort Study
por: Chiang, Hsiu-Yin, et al.
Publicado: (2018)

HPV infection and p53 inactivation in pterygium
por: Tsai, Yi-Yu, et al.
Publicado: (2009)

Globo H Is a Promising Theranostic Marker for Intrahepatic Cholangiocarcinoma
por: Hung, Tsai‐Hsien, et al.
Publicado: (2021)

Impact of universal health coverage on urban–rural inequity in psychiatric service utilisation for patients with first admission for psychosis: a 10-year nationwide population-based study in Taiwan
por: Chiang, Chih-Lin, et al.
Publicado: (2016)

Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
por: Wang, Shang-Yu, et al.
Publicado: (2019)

HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy
por: Yeh, Chun-Nan, et al.
Publicado: (2018)

Risk prediction for 30-day mortality among patients with Clostridium difficile infections: a retrospective cohort study
por: Chiang, Hsiu-Yin, et al.
Publicado: (2019)

Non‐small cell lung cancer with gastric metastasis and repeated gastrointestinal bleeding: A rare case report and literature review
por: Shih‐Chun, Chang, et al.
Publicado: (2021)

25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)(2)D(3)
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non-randomized, single-center study
por: Hu, Chia-Hsiang, et al.
Publicado: (2020)

N3 Subclassification Incorporated into the Final Pathologic Staging of Gastric Cancer: A Modified System Based on Current AJCC Staging
por: Yeh, Chun-Nan, et al.
Publicado: (2015)

Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway
por: Chung, Shin-Yi, et al.
Publicado: (2021)

WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer
por: Chiang, Kun-Chun, et al.
Publicado: (2015)

Risk factors in progression from endometriosis to ovarian cancer: a cohort study based on medical insurance data
por: Chiang, An Jen, et al.
Publicado: (2018)

Body Weight Gain Status during the Incubator Weaning Process in Very Low Birth Weight Premature Infants
por: Lin, Chung-Wei, et al.
Publicado: (2022)

Acute Kidney Injury in the Outpatient Setting Associates with Risk of End-Stage Renal Disease and Death in Patients with CKD
por: Yeh, Hung-Chieh, et al.
Publicado: (2019)

Prospects of Coffee Leaf against SARS-CoV-2 Infection
por: Wu, Chen-Shiou, et al.
Publicado: (2022)

The Relationship between the Second-Generation Antipsychotics Efficacy and the Traditional Chinese Medicine Body Constitutions in Patients with Schizophrenia
por: Yeh, Tzu-Pei, et al.
Publicado: (2021)

The prognostic significance of the alterations of pulmonary hemodynamics in patients with pulmonary arterial hypertension: a meta-regression analysis of randomized controlled trials
por: Sung, Shih-Hsien, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_72tsd1r90rgd5d73olmktt5dnj